Humanigen Inc (fka HGENQ)

[cowtown jay]

POP/STOP

In regards to most recently adding to my position, I had said that my decision was influenced by our CMML trial co-investigator's excitement about the promising results of that trial, coming at the same time that Gilead scraps their trial, using magrolimab.

So, indication of a big leap forward for Humanigen, and a major defeat for Gilead.

Then, we hit a wall of our own, by the resignation of three Board Members, including the two independent members, which caused a Nasdaq non-conformance and delisting.

There was no justifiable reason for those immediate resignations. NONE. Hohnecker and Xie could have given notice of their intent to resign, rather than to breach their fiduciary duty to us shareholders and to Humanigen.

Hohnecker, in particular, should have fulfilled his fiduciary duty. It seems to me that he is another of what I consider as those "plug-and-play" senior leadership executives, like I considered Tim Morris. Look at Hohnecker's other current Board Memberships with Curis, Aravive, and Trishula. What kind of signal does this send to them?

https://www.linkedin.com/in/john-hohneker-407ab115?original_referer=https%3A%2F%2Fwww.google.com%2F

And Xie's role as Gracell's Chief Financial Officer is noteworthy.

https://www.linkedin.com/in/kevin-xie-a9a528?challengeSource=AgEN_ubVAfA1IgAAAYm_mlkEIhOLT47fdA4GQICdhZ389tXSJ4XuHqwmX3COf1c&challegeType=AgHUztjUXMOmgwAAAYm_mlkIQts9dT1mGNr7G8w1TT9197Zny47WrQk&memberId=AgH7rCqkNyRosgAAAYm_mlkLsxJBk7N291b-0p1CaXCve1E&recognizeDevice=AgGAhpLkqGJIVwAAAYm_mlkPChrIwnXVbPZYE9RAD4i5TkatiBWx&challengeId=AQFSOQhGXEg1GAAAAYm_zrz4EkyNpuX9325TSajpQhkTapTaiQtdNSRhoueZBtuYe80ci0vmpnmlsmwMLyh3tShxBtaEtPxTIw&submissionId=7c495c3d-0023-7817-053d-be9f31bc513c&challengeSource=AgHxp5zf9nIUIwAAAYm_z90QwNeFUUAapnS1CPSCAucOOeotOwaKFdyfOvlqHLI&challegeType=AgFjwhLpklM-GAAAAYm_z90Uk5TeFwsPw2BL8yOf9_BEDvxQjELu1_M&memberId=AgFR6BXfq5rq3AAAAYm_z90XDLOUfO4rZMVWPjvn1MuyGxs&recognizeDevice=AgENhoqvIb2VOwAAAYm_z90a2s9HW-XJ48yiTy-m9Qn7atAybpSO

"Gracell reports impressive data with one-day CAR-T for leukaemia
Takes fight to Novartis and Gilead"

Does our CAR-T represent a challenge to Gracell, as Gilead did?

https://www.pmlive.com/pharma_news/gracell_reports_impressive_data_with_one-day_car-t_for_leukaemia_1301432

These gentlemen could very well be of impeccable character, and I don't mean to impugn that. But they appear to have breached their fiduciary duty to me and all Humanigen shareholders, as well as to the company. I am extremely upset about the damage they have caused to all of us. I think it is understandable that I should want to know why they did this.